scispace - formally typeset
D

David K. Blough

Researcher at University of Washington

Publications -  112
Citations -  10711

David K. Blough is an academic researcher from University of Washington. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 48, co-authored 112 publications receiving 9725 citations. Previous affiliations of David K. Blough include Duke University & Fred Hutchinson Cancer Research Center.

Papers
More filters
Journal ArticleDOI

Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.

Helen E. Smith, +10 more
- 01 Nov 2008 - 
TL;DR: Inheritance of CYP2C8*3 is associated with a higher risk of developing renal toxicity in patients treated chronically with CNIs, and especially Tac, possibly by reducing formation of kidney protecting vasodilatory epoxyeicosatrienoic acids.
Journal ArticleDOI

Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer

Megan D. Fesinmeyer, +6 more
- 01 Nov 2010 - 
TL;DR: Treatment interruptions seem to influence survival time among patients with laryngeal tumors completing a full course of radiotherapy, and at all head-and-neck sites, the association between interruptions and survival is sensitive to confounding by stage and other treatments.
Journal ArticleDOI

Characterization of prescribing errors in an internal medicine clinic.

Emily Beth Devine, +8 more
- 15 May 2007 - 
TL;DR: A pilot study was conducted to characterize the epidemiology of prescribing errors, comparing those that occurred pre- to postimplementation of an electronic prescribing system and the results of the study during the preimplementation phase, when a handwritten prescription process was still in place.
Journal ArticleDOI

Benzodiazepine use and physical performance in community-dwelling older women.

Shelly L. Gray, +7 more
- 01 Nov 2003 - 
TL;DR: To determine whether benzodiazepine use in older women increased the risk of decline in physical function, a large sample of women aged 60 and over was surveyed.
Journal ArticleDOI

Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation.

Jeannine S. McCune, +5 more
- 01 Jul 2005 - 
TL;DR: CYP3A5*1 genotype is associated with higher rates of ifosfamide N-dechloroethylation in human liver and kidneys, and is significantly associated with CYP3A4 and CYP 3A5 protein concentration but not with age, sex, or CYP2B6 protein concentration.